Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology.
about
Anti-vascular endothelial growth factor for diabetic macular oedemaAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedemaA Review on Recent Developments for Detection of Diabetic RetinopathyTemsirolimus inhibits proliferation and migration in retinal pigment epithelial and endothelial cells via mTOR inhibition and decreases VEGF and PDGF expressionLong-term efficacy of ciliary muscle gene transfer of three sFlt-1 variants in a rat model of laser-induced choroidal neovascularizationIdentification of novel drug targets for the treatment of diabetic retinopathy.Anti-vascular endothelial growth factor acts on retinal microglia/macrophage activation in a rat model of ocular inflammationEffect of pyridone agent on blood-retinal barrier in diabetic mice.Diabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis.Ranibizumab: the first vascular endothelial growth factor inhibitor approved for the treatment of diabetic macular edema.Current status in diabetic macular edema treatments.An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetesEvolving strategies in the management of diabetic retinopathyDifferential angiogenic properties of lithium chloride in vitro and in vivo.One-Year Feasibility Study of Replenish MicroPump for Intravitreal Drug Delivery: A Pilot Study.The Chemokine Platelet Factor-4 Variant (PF-4var)/CXCL4L1 Inhibits Diabetes-Induced Blood-Retinal Barrier BreakdownMacular ischemia and outcome of vitrectomy for diabetic macular edema.O-GlcNAc modification of transcription factor Sp1 mediates hyperglycemia-induced VEGF-A upregulation in retinal cells.Diabetic retinopathy: intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema.Posterior sub-tenon's bevacizumab injection in diabetic macular edema; a pilot study.Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis.Therapeutic effect of apatinib-loaded nanoparticles on diabetes-induced retinal vascular leakage.Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.The effects of anti-vascular endothelial growth factor agents on human retinal pigment epithelial cells under high glucose conditions.Changes in TL1A levels and associated cytokines during pathogenesis of diabetic retinopathy.Imaging of the parafoveal capillary network in diabetes.Vascular endothelial growth factor trap-eye (Aflibercept) for the management of diabetic macular edemaAnti-VEGF therapy for diabetic macular edema.Are reactive oxygen species still the basis for diabetic complications?Receptor mediated disruption of retinal pigment epithelium function in acute glycated-albumin exposure.Retinal microangiopathy in a mouse model of inducible mural cell loss.Resveratrol reverses the adverse effects of bevacizumab on cultured ARPE-19 cells.New insights into the management of diabetic retinopathy.Effects of commonly used intravitreal anti-vascular endothelial growth factor drugs on mesenchymal stem cells derived from the limbus and ciliary body.Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline.
P2860
Q24193083-F8875C76-5116-48E5-8C42-1B383E8A28A0Q24202071-E9ABD0E4-8FC2-453B-979E-CEA2C43D8881Q28079428-F6EEE533-A2AF-48A9-AC64-DA9B1FA7740AQ28540142-BA64F8F2-6BFE-4035-AA99-7AA48F55BCA2Q28582445-D0476D51-E8D9-4BA1-A143-7C9ABCCF346EQ31134280-F66EA285-B04A-44B4-8565-DB728BD9779DQ33793109-F3E93D91-6817-47B0-8EA9-F02C97B4C171Q33914683-643B8A8D-91FE-4B30-99F9-120D3F6033B6Q34216036-EAB5D78F-E0FA-4490-AED1-361C731A5A2AQ34711043-9EC978E1-F994-4326-B6B6-7AEAEE8BB1E9Q35023708-0E4BFB00-D4B7-48E1-AA5A-CB6017254CD1Q35050146-B0329372-086B-4DF0-808C-582F845A9DC0Q35067102-D61FAFD5-09E7-4A3D-B1B0-B55C00665AE0Q35153964-D478E7D2-D5D7-4575-80E3-0F87432143C4Q35167647-B07BCE7A-12CA-4B73-BCE3-0B0E2E168115Q35195333-02A5F5B0-7100-46D9-87AC-D0FA10124E8BQ35728048-2FF09F8A-75EE-430F-99F2-E9AFD90A9CCCQ35970441-1D06BCB7-B6F5-4B05-BF8E-82A2F79213F1Q35975239-35E060A7-0A29-4276-85EA-AC47DA96F293Q36221554-5C6FDE45-0064-4FD3-9E51-B5DC563C508FQ36762577-86530718-7BF0-45E6-A752-1363D8A79D21Q37082827-4085CE4A-43A7-4414-B517-601FB67837D1Q37627442-A376756C-165C-443F-BC07-F28BD6158CB1Q37647798-0AAC49D5-DD47-4EBC-AA99-C2FD2BE36E60Q37720009-FD7E321E-2AA9-4FE9-BB8B-6A2664620950Q38111698-E92EC7B2-E984-40F6-A9C2-DD77BA60D853Q38174892-324368EC-DCC5-4CE0-B1C1-65FA1FB142CBQ38219571-98DEF585-62B2-450A-80C0-8611DFE2C15FQ38451253-5F116853-D045-4CBE-BC5C-60ACB3EDB7AEQ40839421-AD6179BF-5085-4C44-A605-A950D2F450E7Q41816335-C15B4D84-ACDB-4E96-BD02-3F3FCA2849D2Q42363696-828CFA4A-311A-46DC-BB25-2ECCC7C1E7E6Q42864970-C15F1375-BA4C-407C-91F4-4C36A68BF6C3Q48294574-F6F172F1-388C-412B-973B-5C24CED6533EQ54942391-F8B151B1-C777-4D36-A183-E85EF5DB2D34
P2860
Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Anti-vascular endothelial grow ...... ican Academy of Ophthalmology.
@ast
Anti-vascular endothelial grow ...... ican Academy of Ophthalmology.
@en
Anti-vascular endothelial grow ...... ican Academy of Ophthalmology.
@nl
type
label
Anti-vascular endothelial grow ...... ican Academy of Ophthalmology.
@ast
Anti-vascular endothelial grow ...... ican Academy of Ophthalmology.
@en
Anti-vascular endothelial grow ...... ican Academy of Ophthalmology.
@nl
prefLabel
Anti-vascular endothelial grow ...... ican Academy of Ophthalmology.
@ast
Anti-vascular endothelial grow ...... ican Academy of Ophthalmology.
@en
Anti-vascular endothelial grow ...... ican Academy of Ophthalmology.
@nl
P2093
P1433
P1476
Anti-vascular endothelial grow ...... ican Academy of Ophthalmology.
@en
P2093
Allen C Ho
Franco M Recchia
Gary C Brown
Ingrid U Scott
Melissa M Brown
Michael S Ip
Stephen J Kim
P304
P356
10.1016/J.OPHTHA.2012.07.058
P577
2012-08-20T00:00:00Z